Skip to main content
Login
Contact
Subscribe
Search form
Search
The Punxsutawney Spirit
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Local Guide
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Merck & Co
(NY:
MRK
)
79.50
USD
+0.06 (+0.08%)
Streaming Delayed Price
/ Updated:
9:06 AM EDT, Jul 16, 2020
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
5,808
Open
79.44
Bid (Size)
79.01 (1)
Ask (Size)
79.60 (1)
Prev. Close
79.44
Today's Range
79.30 - 80.00
52wk Range
65.25 - 92.64
Shares Outstanding
2,690,303,898
Dividend Yield
2.42%
Performance
YTD
-13.62%
-13.62%
1 Month
+7.40%
+7.40%
3 Month
-3.13%
-3.13%
6 Month
-13.15%
-13.15%
1 Year
-2.56%
-2.56%
Top News
More News
Clinical Trials for Evolving Targeted Therapies Fueling Gains for Brain Tumor Therapeutics Market
July 15, 2020
category
Featured News
from
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Clinical Trials for Evolving Targeted Therapies Fueling Gains for Brain Tumor Therapeutics Market
July 15, 2020
Financialnewsmedia.com News Commentary
Read More
from
PR Newswire
More News
Read More
Oncorus Announces Clinical Trial Collaboration with Merck to Evaluate the Combination of Oncorus’ ONCR-177 with Merck’s KEYTRUDA® (pembrolizumab)...
Today 7:01 EDT
from
Business Wire News Releases
FDA Grants Priority Review to Merck’s New Drug Application for Vericiguat
Today 6:45 EDT
from
Business Wire News Releases
Merck Animal Health Receives U.S. FDA Approval of BRAVECTO® (fluralaner) Monthly Chews
July 09, 2020
from
Business Wire News Releases
Why Nextleaf Solutions Is Betting That Patents Are The Future Of Cannabis
July 15, 2020
category
NextLeaf Solutions
,
MRK
,
Benzinga
, and 14 more.
from
Benzinga
FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA® (pembrolizumab) for Second-Line Treatment of Patients With Relapsed or Refractory Classical Hodgkin Lymph
July 09, 2020
from
Business Wire News Releases
Merck Announces Appointment of Organon & Co. General Counsel
July 08, 2020
from
Business Wire News Releases
LYNPARZA® (olaparib) Approved in the EU for Germline BRCA-mutated Metastatic Pancreatic Cancer
July 08, 2020
from
Business Wire News Releases
Market Briefing For Thursday, July 16
Today 3:46 EDT
category
Pharma/Biotech
,
Stocks / Equities
,
Consumer Goods
, and 1 more.
from
Blogs - TalkMarkets
Dow Movers: MSFT, MCD
July 14, 2020
category
Stocks
from
Market News Video
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
